Maintenance capecitabine is beneficial in NPC

Nat Rev Clin Oncol. 2022 Apr;19(4):220. doi: 10.1038/s41571-022-00618-0.
No abstract available

Publication types

  • Comment

MeSH terms

  • Capecitabine / therapeutic use
  • Fluorouracil* / therapeutic use
  • Humans
  • Nasopharyngeal Carcinoma / drug therapy
  • Nasopharyngeal Carcinoma / pathology
  • Nasopharyngeal Neoplasms* / drug therapy
  • Nasopharyngeal Neoplasms* / mortality
  • Nasopharyngeal Neoplasms* / pathology
  • Progression-Free Survival

Substances

  • Capecitabine
  • Fluorouracil